Epilim and Pregnancy A study carried out at the University of Liverpool has found that children born to mothers who took sodium valproate (Epilim) were six times more likely to have neurodevelopmental problems including autism and ADHD. They found that the risk was even higher
Working with the Medicines Industry 1. Introduction This statement covers arrangements for the Tuberous Sclerosis Association (TSA) working and interacting with the pharmaceutical and biotechnology organisations and covers all activities related to: • Research and development • Sponsorship of events, awards and publications • Public
Think you can help drive forward our research strategy and raise the profile of the TSA nationally and across the world? Â Then this exciting opportunity could be for you. Head of Research (HOR01) We have a fantastic opportunity for a talented and motivated individual to
Cabinet Secretary for Health and Well-Being, The Scottish Government Dear Mr Neil, As the Scottish Government considers its response to the recent New Medicines Reviews, focusing on decisions made about which health treatments are funded within the NHS, we must remember that the decisions they make
We are delighted to announce that Jean Wilson, founder member of the TSA and former Trustee has made a very welcome return to the Board. Champion of the rights of people with profound learning disabilities, Chair of charity Centre 404 and social work consultant, Jean
In November 2012 we launched our membership survey. The survey report gives a "snap shot" across a range of issues. The recommendations the report contains, which have been accepted by the Board of Trustees, reflect the views and experiences of the 205 TSA members who
It has come to our attention that there has been an administrative delay with items sent to the new PO Box Address: PO Box 71662, London NW3 9TE. Please accept our sincere apologies if you have sent a cheque/correspondence to this address, and have not
NICE have issued new guidance on the assessment and management of autism in children and young people.  This new guidance recommends a range of treatments and interventions to help ensure management addresses the person’s individual needs.  Interventions covered include anticipating, preventing and managing challenging
The Tuberous Sclerosis Alliance (TS Alliance) has formally announced newly updated clinical consensus guidelines for the diagnosis, surveillance and management of tuberous sclerosis complex (TSC). The 2012 International Tuberous Sclerosis Complex Consensus Group comprised 79 specialists from 14 countries. The recommendations are relevant to the
